Exploratory Clinical Study on the Safety and Efficacy of Vascular Intervention Surgery Control System Combined with Thrombectomy Stent and Microcatheter in Treating Acute Ischemic Stroke
Study Name: Exploratory Clinical Study on the Safety and Efficacy of Vascular Intervention Surgery Control System Combined with Thrombectomy Stent and Microcatheter in Treating Acute Ischemic Stroke
Site: Beijing Tiantan Hospital, Capital Medical University
Sponsor: Hangzhou Dinova Brain Nerve MedTech
HGRAC Approval Time: October 2023
Note: HGRAC Approval or Filing (Human Genetic Resource Administration of China) is an important step before the first enrollment of subjects for clinical trials in China sponsored by foreign companies.
A Real-World Study Evaluating the Clinical Performance and Safety of the Da Vinci SP Single-Port Endoscopic Surgery System for Thoracoscopic Single-Port Surgery
Study Name: A Real-World Study Evaluating the Clinical Performance and Safety of the Da Vinci SP Single-Port Endoscopic Surgery System for Thoracoscopic Single-Port Surgery
Site: Hainan Hospital of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (Hainan Boao Research Hospital)
Sponsor: Intuitive Surgical, Inc.
HGRAC Approval Time: October 2023
Note: HGRAC Approval or Filing (Human Genetic Resource Administration of China) is an important step before the first enrollment of subjects for clinical trials in China sponsored by foreign companies.
A Single-Center, Single-Arm, Prospective Real-World Study to Evaluate the Safety and Efficacy of the pEGASUS Intracranial Stent in Assisting the Treatment of Intracranial Aneurysms
Study name: A Single-Center, Single-Arm, Prospective Real-World Study to Evaluate the Safety and Efficacy of the pEGASUS Intracranial Stent in Assisting the Treatment of Intracranial Aneurysms
Leading site: Hainan Hospital of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (Hainan Boao Research Hospital)
Sponsor: Wallaby Medical
HGRAC Approval Time: October 2023
Note: HGRAC Approval or Filing (Human Genetic Resource Administration of China) is an important step before the first enrollment of subjects for clinical trials in China sponsored by foreign companies.